Ellington Management Group’s United Therapeutics UTHR Stock Holding History

Ellington Management Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,300	Closed	-$313K	–	425
2020 Q1	$313K	Sell	3,300 -3,100	-48%	-$295K	0.07%	318
2019 Q4	$564K	Buy	+6,400	New	+$563K	0.12%	145
2019 Q2	–	Sell	-3,100	Closed	-$364K	–	792
2019 Q1	$364K	Sell	3,100 -900	-23%	-$105K	0.07%	305
2018 Q4	$436K	Buy	4,000 +1,200	+43%	+$139K	0.13%	170
2018 Q3	$358K	Buy	+2,800	New	+$346K	0.1%	286
2018 Q1	–	Sell	-6,800	Closed	-$1.01M	–	1041
2017 Q4	$1.01M	Buy	+6,800	New	+$864K	0.16%	93
2017 Q1	–	Sell	-5,700	Closed	-$818K	–	886
2016 Q4	$818K	Sell	5,700 -1,700	-23%	-$217K	0.12%	110
2016 Q3	$874K	Buy	+7,400	New	+$889K	0.24%	92
2016 Q1	–	Sell	-3,000	Closed	-$470K	–	714
2015 Q4	$470K	Buy	+3,000	New	+$437K	0.17%	143
2015 Q3	–	Sell	-1,200	Closed	-$209K	–	910
2015 Q2	$209K	Sell	1,200 -2,100	-64%	-$378K	0.05%	582
2015 Q1	$569K	Buy	+3,300	New	+$503K	0.12%	246
2014 Q3	–	Sell	-5,600	Closed	-$496K	–	472
2014 Q2	$496K	Buy	+5,600	New	+$539K	0.23%	118

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ellington Management Group's UTHR Position: Q2 2020 in Review

Ellington Management Group sold out of United Therapeutics (UTHR) in Q2 2020, closing a stake of 3,300 shares — an estimated $313K sold.

Ellington Management Group first reported a position in UTHR in Q2 2014 and held it in 12 quarters. The position peaked at $1.01M in Q4 2017. 349 funds tracked by Wall St. Rank hold UTHR as of Q2 2020.

Ellington Management Group reported no remaining United Therapeutics position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 3,300 United Therapeutics shares in Q2 2020, an estimated $313K.
Ellington Management Group first reported a position in United Therapeutics in Q2 2014 and held it in 12 quarters.
Ellington Management Group's United Therapeutics position peaked at $1.01M in Q4 2017.
349 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.